Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

NCT04065906 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT04065906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04065906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 15, 2019
Completion date
December 31, 2020
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder (adhd), neurofeedback